BioCentury | Jun 25, 2009
Strategy

Science for export

...current exchange rates were applied. Company Technology summary Year founded Location $ raised Emory University altiris...
BioCentury | Oct 13, 2008
Company News

Calistoga management update

...Seattle, Wash. Business: Cancer, Inflammation Hired: Carol Gallagher as CEO, formerly president and CEO of Metastatix...
BioCentury | Oct 9, 2008
Company News

Calistoga names Gallagher CEO

...Wash.) hired Carol Gallagher as CEO. Previously, she was president and CEO of cancer company Metastatix...
BioCentury | Sep 4, 2008
Targets & Mechanisms

CXCR4 for CNS Infections

...inflammation that can have pathologic consequences." Traffic jam Sofia Ribeiro, director of cell biology at Metastatix...
...then restore normal T cell trafficking in the CNS would have a huge therapeutic advantage." Metastatix...
...CXCR4 antagonists when treating CNS infections. Companies and Institutions Mentioned Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. Metastatix...
BioCentury | Feb 7, 2008
Targets & Mechanisms

Unraveling Bv8

...I Myelopoiesis factors Prokineticin 2 (PROK2; Bv8) Genentech Antibody [Bv8] Preclinical Stromal cell-derived factor-1 (SDF-1) Metastatix...
BioCentury | Dec 10, 2007
Clinical News

MSX-122: Phase I started

...Metastatix began an open-label, dose-escalation, U.S. Phase I trial in patients. Metastatix Inc. , Tucker, Ga...
BioCentury | Nov 12, 2007
Clinical News

MSX-122: Submitted IND

...Metastatix submitted an IND to begin a Phase I trial. Metastatix Inc. , Tucker, Ga. Product...
BioCentury | Oct 22, 2007
Company News

Metastatix management update

Metastatix Inc. , Tucker, Ga. Business: Cancer, Infectious Hired: Carol Gallagher as president and CEO, formerly SVP of corporate development and commercial affairs at Anadys Pharmaceuticals Inc. WIR Staff...
BioCentury | Oct 15, 2007
Company News

Metastatix board of directors update

Metastatix Inc. , Tucker, Ga. Business: Cancer, Infectious Appointed: James Topper, general partner of Frazier Healthcare Ventures WIR Staff cancer Infectious...
BioCentury | Oct 10, 2007
Financial News

Metastatix raises $35 million

...One; MedImmune Ventures; Georgia Venture Partners; Centrosome Ventures; and the State of Georgia also participated. Metastatix's...
...inhibitor that is in preclinical development for solid tumors. Frazier's James Topper will join Metastatix's...
Items per page:
1 - 10 of 12
BioCentury | Jun 25, 2009
Strategy

Science for export

...current exchange rates were applied. Company Technology summary Year founded Location $ raised Emory University altiris...
BioCentury | Oct 13, 2008
Company News

Calistoga management update

...Seattle, Wash. Business: Cancer, Inflammation Hired: Carol Gallagher as CEO, formerly president and CEO of Metastatix...
BioCentury | Oct 9, 2008
Company News

Calistoga names Gallagher CEO

...Wash.) hired Carol Gallagher as CEO. Previously, she was president and CEO of cancer company Metastatix...
BioCentury | Sep 4, 2008
Targets & Mechanisms

CXCR4 for CNS Infections

...inflammation that can have pathologic consequences." Traffic jam Sofia Ribeiro, director of cell biology at Metastatix...
...then restore normal T cell trafficking in the CNS would have a huge therapeutic advantage." Metastatix...
...CXCR4 antagonists when treating CNS infections. Companies and Institutions Mentioned Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. Metastatix...
BioCentury | Feb 7, 2008
Targets & Mechanisms

Unraveling Bv8

...I Myelopoiesis factors Prokineticin 2 (PROK2; Bv8) Genentech Antibody [Bv8] Preclinical Stromal cell-derived factor-1 (SDF-1) Metastatix...
BioCentury | Dec 10, 2007
Clinical News

MSX-122: Phase I started

...Metastatix began an open-label, dose-escalation, U.S. Phase I trial in patients. Metastatix Inc. , Tucker, Ga...
BioCentury | Nov 12, 2007
Clinical News

MSX-122: Submitted IND

...Metastatix submitted an IND to begin a Phase I trial. Metastatix Inc. , Tucker, Ga. Product...
BioCentury | Oct 22, 2007
Company News

Metastatix management update

Metastatix Inc. , Tucker, Ga. Business: Cancer, Infectious Hired: Carol Gallagher as president and CEO, formerly SVP of corporate development and commercial affairs at Anadys Pharmaceuticals Inc. WIR Staff...
BioCentury | Oct 15, 2007
Company News

Metastatix board of directors update

Metastatix Inc. , Tucker, Ga. Business: Cancer, Infectious Appointed: James Topper, general partner of Frazier Healthcare Ventures WIR Staff cancer Infectious...
BioCentury | Oct 10, 2007
Financial News

Metastatix raises $35 million

...One; MedImmune Ventures; Georgia Venture Partners; Centrosome Ventures; and the State of Georgia also participated. Metastatix's...
...inhibitor that is in preclinical development for solid tumors. Frazier's James Topper will join Metastatix's...
Items per page:
1 - 10 of 12